Logo image of LUXH

LUXURBAN HOTELS INC (LUXH) Stock Fundamental Analysis

NASDAQ:LUXH - Nasdaq - US21985R3030 - Common Stock - Currency: USD

0.32  -0.37 (-53.5%)

After market: 0.317 0 (-0.94%)

Fundamental Rating

2

Taking everything into account, LUXH scores 2 out of 10 in our fundamental rating. LUXH was compared to 65 industry peers in the Real Estate Management & Development industry. LUXH may be in some trouble as it scores bad on both profitability and health. LUXH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LUXH was profitable.
In the past year LUXH has reported a negative cash flow from operations.
In the past 5 years LUXH always reported negative net income.
In the past 5 years LUXH reported 4 times negative operating cash flow.
LUXH Yearly Net Income VS EBIT VS OCF VS FCFLUXH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of LUXH (-74.66%) is worse than 91.80% of its industry peers.
Industry RankSector Rank
ROA -74.66%
ROE N/A
ROIC N/A
ROA(3y)-31.72%
ROA(5y)-235.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LUXH Yearly ROA, ROE, ROICLUXH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 1K 2K

1.3 Margins

LUXH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LUXH Yearly Profit, Operating, Gross MarginsLUXH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

LUXH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LUXH has less shares outstanding
Compared to 1 year ago, LUXH has an improved debt to assets ratio.
LUXH Yearly Shares OutstandingLUXH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
LUXH Yearly Total Debt VS Total AssetsLUXH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -3.31, we must say that LUXH is in the distress zone and has some risk of bankruptcy.
LUXH has a worse Altman-Z score (-3.31) than 88.52% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.31
ROIC/WACCN/A
WACC47.34%
LUXH Yearly LT Debt VS Equity VS FCFLUXH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 -5M -10M -15M

2.3 Liquidity

LUXH has a Current Ratio of 0.03. This is a bad value and indicates that LUXH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.03, LUXH is not doing good in the industry: 96.72% of the companies in the same industry are doing better.
LUXH has a Quick Ratio of 0.03. This is a bad value and indicates that LUXH is not financially healthy enough and could expect problems in meeting its short term obligations.
LUXH has a worse Quick ratio (0.03) than 96.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
LUXH Yearly Current Assets VS Current LiabilitesLUXH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for LUXH have decreased strongly by -16327.37% in the last year.
The Revenue for LUXH has decreased by -19.87% in the past year. This is quite bad
LUXH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 103.08% yearly.
EPS 1Y (TTM)-16327.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15123.51%
Revenue 1Y (TTM)-19.87%
Revenue growth 3Y103.08%
Revenue growth 5YN/A
Sales Q2Q%-57.92%

3.2 Future

Based on estimates for the next years, LUXH will show a very strong growth in Earnings Per Share. The EPS will grow by 31.90% on average per year.
LUXH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.67% yearly.
EPS Next Y-217.94%
EPS Next 2Y-20.16%
EPS Next 3Y31.9%
EPS Next 5YN/A
Revenue Next Year-5.75%
Revenue Next 2Y4.34%
Revenue Next 3Y46.34%
Revenue Next 5Y44.67%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LUXH Yearly Revenue VS EstimatesLUXH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
LUXH Yearly EPS VS EstimatesLUXH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 5 10 15 20 25

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

LUXH is valuated cheaply with a Price/Earnings ratio of 1.00.
98.36% of the companies in the same industry are more expensive than LUXH, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.34. LUXH is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 1.57, the valuation of LUXH can be described as very cheap.
Based on the Price/Forward Earnings ratio, LUXH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.03. LUXH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 1
Fwd PE 1.57
LUXH Price Earnings VS Forward Price EarningsLUXH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LUXH Per share dataLUXH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as LUXH's earnings are expected to grow with 31.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.16%
EPS Next 3Y31.9%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LUXH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUXURBAN HOTELS INC

NASDAQ:LUXH (1/16/2025, 8:00:01 PM)

After market: 0.317 0 (-0.94%)

0.32

-0.37 (-53.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)N/A N/A
Inst Owners12.59%
Inst Owner Change-99.93%
Ins Owners7.23%
Ins Owner Change0%
Market Cap723.20K
Analysts43.33
Price TargetN/A
Short Float %2.4%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-0.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-43.22%
Min Revenue beat(2)-54.1%
Max Revenue beat(2)-32.34%
Revenue beat(4)1
Avg Revenue beat(4)-26.12%
Min Revenue beat(4)-54.1%
Max Revenue beat(4)3.09%
Revenue beat(8)3
Avg Revenue beat(8)-19.78%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1
Fwd PE 1.57
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.32
EY100%
EPS(NY)0.2
Fwd EY63.75%
FCF(TTM)-21.19
FCFYN/A
OCF(TTM)-21.22
OCFYN/A
SpS32.21
BVpS-33.6
TBVpS-33.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -74.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.72%
ROA(5y)-235.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -3.31
F-Score2
WACC47.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16327.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15123.51%
EPS Next Y-217.94%
EPS Next 2Y-20.16%
EPS Next 3Y31.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.87%
Revenue growth 3Y103.08%
Revenue growth 5YN/A
Sales Q2Q%-57.92%
Revenue Next Year-5.75%
Revenue Next 2Y4.34%
Revenue Next 3Y46.34%
Revenue Next 5Y44.67%
EBIT growth 1Y-20552.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-7.8%
EBIT Next 3Y68.28%
EBIT Next 5Y60.38%
FCF growth 1Y-211.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-213.46%
OCF growth 3YN/A
OCF growth 5YN/A